Abpro Bio Statistics

Total Valuation

Abpro Bio has a market cap or net worth of KRW 127.54 billion. The enterprise value is 111.47 billion.

Market Cap	127.54B
Enterprise Value	111.47B

Important Dates

The next estimated earnings date is Wednesday, March 19, 2025.

Earnings Date	Mar 19, 2025
Ex-Dividend Date	n/a

Share Statistics

Abpro Bio has 284.69 million shares outstanding. The number of shares has increased by 3.30% in one year.

Current Share Class	n/a
Shares Outstanding	284.69M
Shares Change (YoY)	+3.30%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.21%
Owned by Institutions (%)	0.46%
Float	264.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.65
PB Ratio	0.98
P/TBV Ratio	1.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-16.17
EV / Sales	4.07
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-14.04

Financial Position

The company has a current ratio of 2.91, with a Debt / Equity ratio of 0.12.

Current Ratio	2.91
Quick Ratio	1.87
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	-1.92
Interest Coverage	-5.27

Financial Efficiency

Return on equity (ROE) is -5.16% and return on invested capital (ROIC) is -5.12%.

Return on Equity (ROE)	-5.16%
Return on Assets (ROA)	-4.75%
Return on Capital (ROIC)	-5.12%
Revenue Per Employee	537.56M
Profits Per Employee	-135.13M
Employee Count	51
Asset Turnover	0.17
Inventory Turnover	1.60

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.50% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-17.50%
50-Day Moving Average	489.48
200-Day Moving Average	494.95
Relative Strength Index (RSI)	48.47
Average Volume (20 Days)	2,334,430

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Abpro Bio had revenue of KRW 27.42 billion and -6.89 billion in losses. Loss per share was -24.21.

Revenue	27.42B
Gross Profit	-138.86M
Operating Income	-11.98B
Pretax Income	-6.93B
Net Income	-6.89B
EBITDA	-10.22B
EBIT	-11.98B
Loss Per Share	-24.21

Full Income Statement

Balance Sheet

The company has 31.30 billion in cash and 15.23 billion in debt, giving a net cash position of 16.07 billion or 56.44 per share.

Cash & Cash Equivalents	31.30B
Total Debt	15.23B
Net Cash	16.07B
Net Cash Per Share	56.44
Equity (Book Value)	130.32B
Book Value Per Share	457.78
Working Capital	42.88B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -600.69 million and capital expenditures -7.34 billion, giving a free cash flow of -7.94 billion.

Operating Cash Flow	-600.69M
Capital Expenditures	-7.34B
Free Cash Flow	-7.94B
FCF Per Share	-27.89

Full Cash Flow Statement

Margins

Gross margin is -0.51%, with operating and profit margins of -43.70% and -25.14%.

Gross Margin	-0.51%
Operating Margin	-43.70%
Pretax Margin	-25.27%
Profit Margin	-25.14%
EBITDA Margin	-37.27%
EBIT Margin	-43.70%
FCF Margin	n/a

Dividends & Yields

Abpro Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.30%
Shareholder Yield	-3.30%
Earnings Yield	-5.40%
FCF Yield	-6.22%

Stock Splits

The last stock split was on August 21, 2017. It was a reverse split with a ratio of 0.2.

Last Split Date	Aug 21, 2017
Split Type	Reverse
Split Ratio	0.2

Scores

Abpro Bio has an Altman Z-Score of 2.47. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.47
Piotroski F-Score	n/a